AF Association News & Events
Cardiac tachyarrhythmias and patient values and preferences for their management
Cardiac tachyarrhythmias are recurrent or chronic and in some cases life-threatening conditions. Heart rhythm disturbances are often highly symptomatic and the psychological impact of the disease can be significant. Patients' beliefs and knowledge about their health (and illness), medications, and healthcare they receive are important determinants of whether or not they accept recommended treatments; influence their coping responses to their illness and treatment; adherence to recommended therapy; and ultimately affects health outcomes. Incorporation of patients' values and preferences for therapy should now be considered as an integral part of the decision-making process and treatment strategy. It is important to acknowledge and understand the impact of cardiac tachyarrhythmias on the patient. To address this issue, a Task Force was convened by the European Heart Rhythm Association (EHRA), and endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), with the remit to comprehensively review the published evidence available, to publish a joint consensus document on patient values and preferences for the management of cardiac tachyarrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice.
Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis
A national screening programme for atrial fibrillation is likely to represent a cost-effective use of resources, with systematic opportunistic screening more likely to be cost-effective than systematic population screening. Nurse pulse palpation or modified blood pressure monitors would be appropriate screening tests, with confirmation by diagnostic 12-lead electrocardiography interpreted by a trained GP, with referral to a specialist in the case of an unclear diagnosis. Implementation strategies to operationalise uptake of systematic opportunistic screening in primary care should accompany any screening recommendations.
Father-of-six Dean reflects on the day his neighbours saved his life after cardiac arrest
Happitech, Arrhythmia Alliance and Bug Labs launch Heart for Heart e-health initiative
Happitech, Arrhythmia Alliance and Bug Labs will announce the launch of the Heart for Heart e-health initiative. This initiative invites people to participate in the world’s largest crowdsourced heart health initiative by inviting them to contribute their heart rhythm data using the free Heart for Heart iPhone App.
Crowdsourcing campaign looks to improve heart health diagnosis
The initiative asks people to donate heart rhythm data through the Heart for Heart smartphone app. Users do so by placing their finger over their phone’s camera and flash.
Drones could be shockingly quick delivering AEDs during cardiac arrest
In recent years, automated external defibrillators (AEDs) have become more common in public spaces such as movie theaters, shopping malls and restaurants. But survival rates for out-of-hospital cardiac arrest remain between 8 and 10 percent.
Heart For Heart
Happitech, Arrhythmia Alliance and Bug Labs will announce the launch of the Heart for Heart campaign during World Heart Rhythm Week. This campaign invites people to participate in the world’s largest crowdsourced heart health initiative by recruiting them to contribute their heart rhythm data using the free Heart for Heart iPhone App.
Interview with Trudie Lobban MBE, Founder & Trustee of Arrhythmia Alliance
Arrhythmia Alliance is a coalition of charities, patient groups, patients, carers, healthcare professionals, policy-makers, politicians, allied professionals and all those involved in the care of or affected by cardiac arrhythmias. Arrhythmia Alliance works in collaboration to improve diagnosis, treatment and quality of life for all those suffering with arrhythmias.
HRS 2017: New implantable string subcutaneous defibrillator shows promise for sudden cardiac death prevention
The results from a first-in-man feasibility study on subcutaneous defibrillation utilising an integrated flexible string shaped defibrillator were presented at the Heart Rhythm Society’s 38th Annual Scientific Sessions (10‒13 May, Chicago, USA) by Petr Neuzil from Na Homolce Hospital in Prague, Czech Republic.